Healthcare
Sofinnova leads €26.5m round for EryDel
Existing shareholders Genextra and Innogest also take part in the investment round
Sofinnova leads €35.5m capital increase for Inventiva
Capital is drawn from Sofinnova Crossover Fund I, which held a final close on €275m in April 2018
NB Renaissance Partners et al. exit Esaote
Chinese consortium wholly acquires the Italian medical imaging company
Andera et al. in €20m series-A for MMI
VC houses Panakès Partners and Fountain Healthcare Partners also took part in the funding round
Vesalius et al. lead $4.6m round for Sword Health
Vesalius deployed capital from its Vesalius Biocapital III fund, which was launched last year
Sofinnova et al. back €27m series-C for Limflow
BPI France and Balestier, a Singaporean family fund, also take part in the financing
Turenne Capital invests €9.8m in Infimed
Turenne acquires a majority stake in the medical device financing business through the transaction
Gilde Healthcare’s Rad-X buys TelradKo
Acquisition will provide TelradKo with fresh capital to accelerate its expansion
Advent International in €1.91bn Zentiva carve-out
GP to buy generics business division Zentiva from French biopharmaceutical company Sanofi
Charterhouse's Cooper-Vemedia buys 12 Sanofi brands for €158m
Deal is the second major bolt-on acquisition for the group since the GP acquired it in 2015
VC firms back £29m series-B for Enterprise Therapeutics
Forbion, Versant, Novartis, Epidarex and IP Group all take part in the financing
PE-backed Wilson Therapeutics in SEK 7.1bn trade sale
Alexion Pharmaceuticals announces a public cash offer to acquire Wilson for SEK 232 per share
Adiuva Capital-backed AC Dental buys NT Dental
Adiuva generally makes investments between €5-40m for majority and minority positions
Folmer exits Jatkopolut to Familar
Familiar is a subsidiary of healthcare and social services firm Mehiläinen, backed by Triton and KKR
Capvis, Partners Group buy Amann Girrbach from TA
Capvis draws equity from its new DACH-focused buyout fund Capvis Equity V, targeting €1bn
Benelux's biotech and pharma buyouts market in rude health
Buyout houses are becoming more attracted to assets in the Benelux biotech and pharma spaces, typically the preserve of venture capital investors
Investindustrial to acquire Lifebrain
Lifebrain was initially funded with capital raised from several Austrian private investors
ArchiMed buys Soest Medical
GP draws equity from its €315m Med II vehicle, which held a final close on its hard-cap in September
CDPQ-backed Datamars acquires Simcro from Riverside
Deal brings a five-year holding period for private equity firm The Riverside Company to an end
Tesi, Debiopharm lead €4.4m series-A for Kaiku Health
Finnish growth investor Prodeko Ventures participated in the round, alongside existing investors
Connection Capital backs HEL
Connection Capital invests £5.9m in the UK-based lab equipment manufacturer to boost growth
Main Capital-backed RVC buys Allgeier
Combined group will operate under the name RVC Medical IT and targets revenues of €10m for 2018
Apposite acquires OrthoD from The Riverside Company
Deal is the fifth investment for healthcare-focused GP Apposite's latest vehicle
Qiming in $12m series-A for LetsGetChecked
Healthcare self-testing company will invest in technology development and recruitment
